Ginkgo Bioworks (NYSE: DNA) today confirmed that it has collected, identified, and sequenced three samples containing the novel BA.3 sublineage of the Omicron variant.
Quest Diagnostics (NYSE:DGX), the nation's leading provider of diagnostic information services, today announced it has formed an agreement with the Texas Department of State Health Services (DSHS) to provide COVID-19...